The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient
Retrospective Observational Study of Impact of Portal Hypertension for the Peptic Ulcer in Liver Cirrhosis and Chronic Hepatitis
1 other identifier
observational
455
1 country
1
Brief Summary
The aim of this study is to assess the role of portal hypertension of peptic ulcer disease in liver cirrhosis and chronic hepatitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 6, 2013
CompletedFirst Posted
Study publicly available on registry
September 18, 2013
CompletedResults Posted
Study results publicly available
July 24, 2014
CompletedJuly 24, 2014
July 1, 2014
3 months
September 6, 2013
January 23, 2014
July 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Association of HVPG and PUD in Patients With Liver Cirrhosis
The association of hepatic vein pressure gradient that reflects portal hypertension and peptic ulcer disease in patients with liver cirrhosis was assessed statistically. (NO specific time frame, only confined to 2009 to 2012, when the HVPG measurement was done). The Mann-Whitney test was used to evaluate the association between PUD or not and HVPG degree, by SPSS software.
Retrospective case-control study (from 2009 to 2012, up to 3 years)
Secondary Outcomes (1)
The Association Between PUD and HVPG in Patients With Chronic Hepatitis
Retrospective case-control study (from 2009 to 2012, up to 3 years)
Study Arms (2)
Patients with chronic hepatitis
Patients with chronic hepatitis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement
Patients with liver cirrhosis
Patients with liver cirrhosis, who experienced HVPG measurement via transjugular approach and EGD within 3 months of HVPG measurement
Eligibility Criteria
Investigators will analyze the medical records of hepatic vein pressure gradient (HVPG) and esophagogastroduodenoscopy (EGD) cases who had LC or chronic hepatitis in single tertiary hospital of Korea.
You may qualify if:
- The patients who underwent hepatic vein pressure gradient (HVPG) measurement and esophagogastroduodenoscopy (EGD) and also had LC or chronic hepatitis
You may not qualify if:
- The patients who have missing or incomplete HVPG or EGD data
- The patients who underwent gastrectomy
- The patients who have systemic malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chuncheon Sacred Heart hospital
Chuncheon, Gangwon-do, 200-704, South Korea
Related Publications (4)
Siringo S, Burroughs AK, Bolondi L, Muia A, Di Febo G, Miglioli M, Cavalli G, Barbara L. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol. 1995 Jun;22(6):633-41. doi: 10.1016/0168-8278(95)80219-3.
PMID: 7560857BACKGROUNDVergara M, Calvet X, Roque M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol. 2002 Jul;14(7):717-22. doi: 10.1097/00042737-200207000-00002.
PMID: 12169979BACKGROUNDKamalaporn P, Sobhonslidsuk A, Jatchavala J, Atisook K, Rattanasiri S, Pramoolsinsap C. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients. Aliment Pharmacol Ther. 2005 Jun 15;21(12):1459-65. doi: 10.1111/j.1365-2036.2005.02507.x.
PMID: 15948813BACKGROUNDBang CS, Baik GH, Kim JH, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ. Peptic ulcer disease in liver cirrhosis and chronic hepatitis: impact of portal hypertension. Scand J Gastroenterol. 2014 Sep;49(9):1051-7. doi: 10.3109/00365521.2014.923501. Epub 2014 Jun 5.
PMID: 24902119DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Chang Seok Bang
- Organization
- Hallym University College of Medicine, Chuncheon Sacred Heart Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Chang Seok Bang, M.D
Department of Internal Medicine, Hallym University College of Medicine
- STUDY CHAIR
Gwang Ho Baik, M.D
Department of Internal Medicine, Hallym University College of Internal Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 6, 2013
First Posted
September 18, 2013
Study Start
May 1, 2013
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
July 24, 2014
Results First Posted
July 24, 2014
Record last verified: 2014-07